Table 2.
Studies |
Effect Estimates |
Mean Differences in TG levels (mmol/L) (smokers – non-smokers) |
|||
---|---|---|---|---|---|
Region | Fixed Effects [95% CI] | I2 (%) | Random Effects [95% CI] | ||
USA & Canada | 11 | 14 | 0.16 [0.09, 0.22] | 42 | 0.17 [0.07, 0.27] |
Europe | 14 | 21 | 0.33 [0.31, 0.36] | 89 | 0.22 [0.11, 0.33] |
Asia | 16 | 21 | 0.61 [0.61, 0.61] | 86 | 0.41 [0.30, 0.51] |
Middle East | 2 | 3 | 0.82 [0.73, 0.91] | 99 | 0.64 [− 0.28, 1.56] |
Indian Subcontinent | 4 | 4 | 0.68 [0.56, 0.79] | 95 | 0.66 [0.16, 1.16] |
Africa | 1 | 1 | NA | NA | NA |
Study Design | |||||
Cross Sectional | 42 | 55 | 0.38 [0.35, 0.40] | 92 | 0.31 [0.21, 0.40] |
Cohort | 6 | 9 | 0.61 [0.61, 0.61] | 95 | 0.42 [0.26, 0.58] |
Period of Publication | |||||
1970 s | 3 | 3 | 0.53 [0.48, 0.58] | 92 | 0.35 [0.05, 0.64] |
1980 s | 15 | 23 | 0.19 [0.13, 0.25] | 35 | 0.19 [0.10, 0.27] |
1990 s | 14 | 19 | 0.28 [0.24, 0.31] | 72 | 0.28 [0.21, 0.36] |
2000 s | 9 | 11 | 0.19 [0.13, 0.25] | 84 | 0.20 [0.04, 0.36] |
2010 s | 6 | 7 | 0.82 [ 0.76, 0.88] | 96 | 0.85 [0.52, 118] |
2020 s | 1 | 1 | NA | NA | NA |
Sexa | |||||
Males | 27 | 32 | 0.38 [0.34, 0.41] | 93 | 0.34 [0.19, 0.48] |
Females | 10 | 12 | 0.18 [0.14, 0.23] | 88 | 0.15 [0.06, 0.24] |
Combined | 17 | 20 | 0.61 [0.61, 0.61] | 68 | 0.43 [0.34, 0.51] |
Total | 48 | 64 | 0.60 [0.60, 0.61] | 95 | 0.32 [0.25, 0.40] |
The sum of studies does not add to 48, as some studies provided multiple stratum-specific estimates.